Bleomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0409-0332

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bleomycin (NDC 0409-0332). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bleomycin 01)

Chemical structure diagram of the active ingredient bleomycin, showing its molecular components and variations labeled as A2 and B2 with specific functional groups.*

FDA Label Image

Logo (Bleomycin 02)

FDA Label Image

Principal Display Panel (30 unit Vial Label)

Label for Bleomycin for Injection, USP, 30 units per vial, powder for injection by Hospira, Inc. The label specifies routes of administration as intravenous, intramuscular, subcutaneous, and intrapleural. It includes a caution about cytotoxic special handling procedures and shows storage instructions and a barcode with the NDC 0409-0323-20.*

FDA Label Image

Principal Display Panel (30 unit Vial Carton)

Packaging label for Bleomycin for Injection, USP, 30 units per vial, a lyophilized powder for solution. The label indicates the vial is sterile and intended for intravenous, intramuscular, subcutaneous, and intrapleural use. It includes warnings about cytotoxic special handling procedures and storage instructions to keep the dry powder refrigerated between 2°-8°C. The labeler is Hospira, Inc., and the product is designated for Rx use only.*

FDA Label Image

Principal Display Panel (15 unit Vial Label)

Bleomycin for Injection, USP 15 units per vial, lyophilized powder for injection. Label indicates use for intravenous, intramuscular, subcutaneous, and intrapleural administration. Includes warnings about cytotoxicity and special handling procedures. Distributed by Hospira, Inc., with storage instructions and dosage guidance visible on the label.*

FDA Label Image

Principal Display Panel (15 unit Vial Carton)

The packaging label for Bleomycin injection, USP, 15 units per vial, powder, lyophilized, for solution. The label indicates it is for intravenous, intramuscular, subcutaneous, and intrapleural use. It is a single-dose vial distributed by Hospira, Inc. The label includes storage instructions and a caution that the product is cytotoxic requiring special handling procedures.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.